Latest Insider Transactions at Generation Bio Co. (GBIO)
This section provides a real-time view of insider transactions for Generation Bio Co. (GBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Generation Bio Co. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Generation Bio Co.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2024
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,131
+2.81%
|
-
|
|
Jan 15
2024
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,897
-0.64%
|
$4,897
$1.91 P/Share
|
|
Jan 15
2024
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,131
+1.81%
|
-
|
|
Jan 15
2024
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,897
-5.36%
|
$4,897
$1.91 P/Share
|
|
Jan 15
2024
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,131
+13.38%
|
-
|
|
Jan 02
2024
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
2,445
-2.23%
|
$2,445
$1.62 P/Share
|
|
Jan 02
2024
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,445
-29.55%
|
$2,445
$1.62 P/Share
|
|
Dec 08
2023
|
Dannielle Appelhans |
BUY
Open market or private purchase
|
Indirect |
7,363
+50.0%
|
$7,363
$1.79 P/Share
|
|
Dec 08
2023
|
Dannielle Appelhans |
BUY
Open market or private purchase
|
Direct |
637
+4.8%
|
$637
$1.82 P/Share
|
|
Dec 04
2023
|
Dannielle Appelhans |
BUY
Open market or private purchase
|
Direct |
12,000
+50.0%
|
$12,000
$1.5 P/Share
|
|
Dec 04
2023
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
150,000
+21.91%
|
$150,000
$1.5 P/Share
|
|
Dec 01
2023
|
Donald William Nicholson |
BUY
Open market or private purchase
|
Direct |
100,000
+31.89%
|
$100,000
$1.44 P/Share
|
|
Dec 01
2023
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
192,960
+33.4%
|
$192,960
$1.31 P/Share
|
|
Dec 01
2023
|
Anthony G. Quinn |
BUY
Open market or private purchase
|
Direct |
88,495
+50.0%
|
$88,495
$1.41 P/Share
|
|
Oct 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-17.2%
|
$3,633
$3.24 P/Share
|
|
Oct 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+36.95%
|
-
|
|
Oct 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.59%
|
$6,549
$3.24 P/Share
|
|
Oct 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+1.96%
|
-
|
|
Oct 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,395
-0.8%
|
$31,185
$3.24 P/Share
|
|
Oct 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,437
+1.77%
|
-
|
|
Oct 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,675
-3.28%
|
$8,025
$3.24 P/Share
|
|
Oct 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,111
+9.68%
|
-
|
|
Oct 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-5.66%
|
$6,549
$3.24 P/Share
|
|
Oct 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+16.17%
|
-
|
|
Oct 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.92%
|
$6,549
$3.24 P/Share
|
|
Oct 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+3.05%
|
-
|
|
Oct 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-1.12%
|
$3,633
$3.24 P/Share
|
|
Oct 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+3.66%
|
-
|
|
Aug 23
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
3,116
-51.68%
|
$12,464
$4.93 P/Share
|
|
Jul 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.59%
|
$10,915
$5.08 P/Share
|
|
Jul 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+1.98%
|
-
|
|
Jul 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,476
-0.58%
|
$37,380
$5.08 P/Share
|
|
Jul 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,437
+1.79%
|
-
|
|
Jul 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,166
-4.7%
|
$15,830
$5.08 P/Share
|
|
Jul 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,785
+13.55%
|
-
|
|
Jul 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-6.55%
|
$10,915
$5.08 P/Share
|
|
Jul 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+18.25%
|
-
|
|
Jul 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-16.72%
|
$6,055
$5.08 P/Share
|
|
Jul 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+36.29%
|
-
|
|
Jul 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.94%
|
$10,915
$5.08 P/Share
|
|
Jul 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+3.11%
|
-
|
|
Jul 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-1.15%
|
$6,055
$5.08 P/Share
|
|
Jul 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+3.76%
|
-
|
|
Jul 03
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,116
-2.98%
|
$15,580
$5.29 P/Share
|
|
Apr 25
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,914
-100.0%
|
$11,656
$4.61 P/Share
|
|
Apr 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-29.36%
|
$4,844
$4.5 P/Share
|
|
Apr 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+50.0%
|
-
|
|
Apr 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.97%
|
$8,732
$4.5 P/Share
|
|
Apr 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+3.18%
|
-
|
|
Apr 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-1.18%
|
$4,844
$4.5 P/Share
|